Natco Pharma Gains 9%, Launches Generic Version of Revlimid in US
Shares of Natco Pharma rallied 9 per cent to Rs 920 on the BSE in Tuesday’s intra-day trade after the company launched its first generic...
Use UNICORN Signals App
By EquityPandit
